Sanger D J
Pharmacol Biochem Behav. 1986 Sep;25(3):537-41. doi: 10.1016/0091-3057(86)90137-1.
Ro 15-1788 and CGS 8216 antagonise many of the pharmacological effects of benzodiazepines but both of these compounds have also been shown to exert behavioral effects when administered alone. In the present study the effects of Ro 15-1788 and CGS 8216, alone and in combination with diazepam and with the benzodiazepine receptor ligand zolpidem, were investigated. Diazepam and zolpidem produced dose-related decreases in rates of food-reinforced lever-pressing maintained by a fixed-ratio (FR 10) schedule. CGS 8216 also reduced response rates although Ro 15-1788, at several doses, produced small, but statistically significant, increases in responding. When the diazepam and zolpidem dose-response curves were re-established in the presence of a dose of Ro 15-1788 or CGS 8216 the depressant effects of the higher doses were antagonised. However, neither diazepam nor zolpidem blocked the rate reducing effect of CGS 8216 which may not therefore be due to an action at benzodiazepine receptors.
Ro 15 - 1788和CGS 8216可拮抗苯二氮䓬类药物的许多药理作用,但这两种化合物单独给药时也已显示出行为效应。在本研究中,对Ro 15 - 1788和CGS 8216单独使用以及与地西泮和苯二氮䓬受体配体唑吡坦联合使用的效果进行了研究。地西泮和唑吡坦使按固定比率(FR 10)程序维持的食物强化杠杆按压速率呈剂量依赖性降低。CGS 8216也降低了反应速率,尽管Ro 15 - 1788在几个剂量下使反应有小幅但具有统计学意义的增加。当在给予一定剂量的Ro 15 - 1788或CGS 8216的情况下重新建立地西泮和唑吡坦的剂量 - 反应曲线时,较高剂量的抑制作用被拮抗。然而,地西泮和唑吡坦均未阻断CGS 8216的速率降低作用,因此其作用可能并非通过苯二氮䓬受体。